Price-focused regulatory changes could limit access to new drugs and dampen R&D investment, writes Richard Owens. By Richard C. Owens, September 17, 2019...
MLI Munk Senior Fellow Richard Owens recently contributed, alongside co-authors Daniel Schwanen (C.D. Howe Institute) and Stephen Ezell (Information Technology and Innovation Foundation),...
The USMCA will unleash innovation and make Canada and Mexico more attractive locations to conduct life-sciences R&D, write Richard Owens, Stephen Ezell, and Alberto...
The Canadian copyright and intellectual-property scene has too long been smothered and defiled by the negative views of anti-copyright and anti-IP activists and...
Forced speech breaches section 2 of the Canadian Charter of Rights and Freedoms, which sets out the fundamental freedoms of conscience, thought and...
Should Canada be concerned about Huawei and Chinese infiltration into Canada's economy? According to a panel of experts, we should absolutely be worried....
We should recognize the failures of Canada's innovation policy industrial complex and strengthen our intellectual property regime, write Richard Owens and Sean Speer ...
OTTAWA, ON (October 2, 2018): The provisions on copyright and patents in the new US-Mexico-Canada Agreement should be seen as wins for Canadians,...
It’s time for Canada to grow up and to purge the defeatist parasitism that sometimes characterizes our policy-making, write Richard Owens and Stephen...
The federal government is proposing dramatic changes to the pricing of new patented medicines in Canada, and it announced in its recent budget...
